Helen McIntosh, MD
Obstetrics & Gynecology · Savannah, GANPI 1306890009
Payments from drug & device makers
Across 231 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$721
- Mayne Pharma Commercial LLC$517
- Bayer$484
- Exeltis, USA Inc.$303
- Astellas Pharma US Inc$233
- Therapeuticsmd, Inc.$222
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,13197%
- Education$1493%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 43 | $721 |
| Mayne Pharma Commercial LLC | 22 | $517 |
| Bayer | 26 | $484 |
| Exeltis, USA Inc. | 17 | $303 |
| Astellas Pharma US Inc | 11 | $233 |
| Therapeuticsmd, Inc. | 16 | $222 |
| Sumitomo Pharma America, Inc. | 8 | $184 |
| Hologic Sales And Service, LLC | 9 | $164 |
| AMAG Pharmaceuticals, Inc. | 10 | $149 |
| Myovant Sciences Inc. | 6 | $124 |
| Scynexis, Inc. | 6 | $110 |
| Mylan Pharmaceuticals Inc. | 5 | $102 |
| Myriad Women's Health, Inc. | 1 | $99 |
| Organon | 5 | $98 |
| Millicent US Inc | 6 | $96 |
| Channel Medsystems, Inc. | 3 | $81 |
| Amgen | 5 | $69 |
| Evofem Biosciences, Inc. | 4 | $63 |
| Agile Therapeutics, Inc. | 4 | $58 |
| Daiichi Sankyo Inc. | 3 | $51 |
| Duchesnay USA Incorporated | 2 | $49 |
| Lupin Inc. | 3 | $41 |
| Merck | 2 | $30 |
| Dexcom, Inc. | 1 | $29 |
| Medical Device Business Services, Inc. | 1 | $26 |
| Roche Diagnostics Corporation | 1 | $25 |
| Avion Pharmaceuticals | 2 | $24 |
| Minerva Surgical, Inc | 2 | $22 |
| LSI Solutions Inc | 1 | $22 |
| Smith+Nephew | 1 | $19 |
| Radius Health, Inc. | 1 | $15 |
| Axonics, Inc. | 1 | $13 |
| Exact Sciences | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Mission Pharmacal Company | 1 | $12 |
How this compares
$4,281 in reported general payments places this provider in the 85th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 15 | $9,338 |
| ImvexxyEstradiol | 29 | $6,467 |
| Estradiol | 76 | $4,514 |
| IntrarosaPrasterone (Dhea) | 11 | $2,822 |
| Estradiol (Once Weekly)Estradiol | 16 | $1,308 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 16 | $747 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 25 | $548 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 22 | $257 |
| Fluconazole | 33 | $129 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $69 |
| Alendronate Sodium | 14 | $66 |
| Zolpidem Tartrate | 22 | $57 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $233 | $9,33815 claims |
| Therapeuticsmd, Inc.Imvexxy | $222 | $6,46729 claims |
| AMAG Pharmaceuticals, Inc.Intrarosa | $149 | $2,82211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Other obstetrics & gynecology in Savannah
- Debra WallandSavannah$196K
- Dina LinfootSavannah$12K
- Gretchen MitchellCumming$4.5M
- Stephen BlankAtlanta$3.5M
- Eric BrownAtlanta$1.7M
- Melissa KottkeAtlanta$1.7M
- Allan DinnersteinFort Stewart$1.5M
- David MontaldiMarietta$1.1M
- Winifred SoufiAtlanta$889K
- Richard ZaneAlpharetta$638K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.